Expert Opinion on Investigational Drugs

1

Selective JAK inhibitors in development for rheumatoid arthritis

Norman, Peter

Journal:

Year:

2014

Language:

english

File:

PDF, 412 KB

english, 2014

2

New investigational drugs for the treatment of neuropathic pain

Sałat, Kinga, Kowalczyk, Paula, Gryzło, Beata, Jakubowska, Anna, Kulig, Katarzyna

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 543 KB

english, 2014

3

Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies

Jackson, V Margaret, Price, David A, Carpino, Philip A

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 325 KB

english, 2014

4

Drugs currently in Phase II clinical trials for cocaine addiction

Kim, Jee Hyun, Lawrence, Andrew J

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 478 KB

english, 2014

5

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Davis, Mellar P

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 572 KB

english, 2014

6

Drugs targeting nitric oxide synthase for migraine treatment

Barbanti, Piero, Egeo, Gabriella, Aurilia, Cinzia, Fofi, Luisa, Della-Morte, David

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 297 KB

english, 2014

7

Mavoglurant as a treatment for Parkinson’s disease

Petrov, Dmitry, Pedros, Ignacio, de Lemos, Maria Luisa, Pallàs, Mercè, Canudas, Anna Maria, Lazarowski, Alberto, Beas-Zarate, Carlos, Auladell, Carme, Folch, Jaume, Camins, Antoni

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 391 KB

english, 2014

8

Current status of drugs in development for celiac disease

Kurppa, Kalle, Hietikko, Minna, Sulic, Ana-Marija, Kaukinen, Katri, Lindfors, Katri

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 727 KB

english, 2014

9

Biomarkers and personalized therapy in chronic kidney diseases

Schena, Francesco Paolo

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 146 KB

english, 2014

10

Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder

Fleisher, Carl, McGough, James

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 281 KB

english, 2014

11

Bedoradrine for treating asthma and chronic obstructive pulmonary disease

Antoniu, Sabina

Journal:

Expert Opinion on Investigational Drugs

Year:

2014

Language:

english

File:

PDF, 506 KB

english, 2014

12

Volume 23; Issue 8

Expert Opinion on Investigational Drugs

Selective JAK inhibitors in development for rheumatoid arthritis

New investigational drugs for the treatment of neuropathic pain

Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies

Drugs currently in Phase II clinical trials for cocaine addiction

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands

Drugs targeting nitric oxide synthase for migraine treatment

Mavoglurant as a treatment for Parkinson’s disease

Current status of drugs in development for celiac disease

Biomarkers and personalized therapy in chronic kidney diseases

Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder

Bedoradrine for treating asthma and chronic obstructive pulmonary disease

Related articles